Evidence map›Paper›PMID 26541328›Full record

Trial reportEuropean journal of nutrition2017

Effect of virgin olive oil and thyme phenolic compounds on blood lipid profile: implications of human gut microbiota.

Sandra Martín-Peláez, Juana Ines Mosele, Neus Pizarro, Marta Farràs, Rafael de la Torre, Isaac Subirana, Francisco José Pérez-Cano, Olga Castañer, Rosa Solà, Sara Fernandez-Castillejo and 4 more

Registry-linked trialAbstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in European journal of nutrition, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04025281 (Post-prandial Effects of Extra Virgin Olive Oil on Endothelial Function in Adults at Risk for Type 2 Diabetes), which is not on this map. Cited by 65 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 4 pooled it
9.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04025281 nacompletednot on this mapstarted 2019, after this paper: background citation

Post-prandial Effects of Extra Virgin Olive Oil on Endothelial Function in Adults at Risk for Type 2 Diabetes: A Randomized Crossover Controlled Trial

TypeinterventionalSponsorGriffin HospitalRan2019 to 2019Enrolled20ConditionsType 2 DiabetesArmsExtra Virgin Olive Oil, Refined Olive Oil
3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 4 syntheses or guidelines pooled it, 123 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Review
  12. Observational
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Olive Oil's Attenuating Effects on Lipotoxicity.Advances in experimental medicine and biology · 2024
    Review

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 2 countries.

Sandra Martín-PeláezCardiovascular Risk and Nutrition Research Group, REGICOR Study Group, Hospital del Mar Research Institute (IMIM), Doctor Aiguader 88, 08003, Barcelona, Spain. s.martin.pelaez@gmail.com.
Juana Ines MoseleFood Technology Department, UTPV-XaRTA, Agrotecnio Research-Center, University of Lleida, Av. Alcalde Rovira Roure 191, 25198, Lleida, Spain.
Neus PizarroHuman Pharmacology and Clinical Neurosciences Research Group, IMIM, Doctor Aiguader 88, 08003, Barcelona, Spain.
Marta FarràsCardiovascular Risk and Nutrition Research Group, REGICOR Study Group, Hospital del Mar Research Institute (IMIM), Doctor Aiguader 88, 08003, Barcelona, Spain.
Rafael de la TorreSpanish Biomedical Research Networking Centre (CIBER), Physiopathology of Obesity and Nutrition (CIBERobn), Instituto de Salud Carlos III, Madrid, Spain.
Isaac SubiranaCardiovascular and Genetic Epidemiology Research Group, REGICOR Study Group, IMIM, Doctor Aiguader 88, 08003, Barcelona, Spain.
Francisco José Pérez-CanoDepartment of Physiology, Faculty of Pharmacy, Institute for Research on Nutrition and Food Safety (INSA-UB), B building, Joan XXIII, 27-30, 08028, Barcelona, Spain.
Olga CastañerCardiovascular Risk and Nutrition Research Group, REGICOR Study Group, Hospital del Mar Research Institute (IMIM), Doctor Aiguader 88, 08003, Barcelona, Spain.
Rosa SolàUnit of Farmacobiology, Facultat de Medicina i Ciències de la Salut, Universitat Rovira I Virgili, Sant Llorenç 21, 43201, Reus, Spain.
Sara Fernandez-CastillejoUnit of Farmacobiology, Facultat de Medicina i Ciències de la Salut, Universitat Rovira I Virgili, Sant Llorenç 21, 43201, Reus, Spain.
Saray HerediaCardiovascular Risk and Nutrition Research Group, REGICOR Study Group, Hospital del Mar Research Institute (IMIM), Doctor Aiguader 88, 08003, Barcelona, Spain.
Magí FarréHuman Pharmacology and Clinical Neurosciences Research Group, IMIM, Doctor Aiguader 88, 08003, Barcelona, Spain.
María José MotilvaFood Technology Department, UTPV-XaRTA, Agrotecnio Research-Center, University of Lleida, Av. Alcalde Rovira Roure 191, 25198, Lleida, Spain.
Montserrat FitóCardiovascular Risk and Nutrition Research Group, REGICOR Study Group, Hospital del Mar Research Institute (IMIM), Doctor Aiguader 88, 08003, Barcelona, Spain. mfito@imim.es.
Hospital Del Mar · ESPompeu Fabra University · ESUniversidad Rovira i Virgili · ESUniversitat de Lleida · ESInstituto de Salud Carlos III · ESUniversitat Autònoma de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo investigate the effect of virgin olive oil phenolic compounds (PC) alone or in combination with thyme PC on blood lipid profile from hypercholesterolemic humans, and whether the changes generated are related with changes in gut microbiota populations and activities.

methodsA randomized, controlled, double-blind, crossover human trial (n = 12) was carried out. Participants ingested 25 mL/day for 3 weeks, preceded by 2-week washout periods, three raw virgin olive oils differing in the concentration and origin of PC: (1) a virgin olive oil (OO) naturally containing 80 mg PC/kg, (VOO), (2) a PC-enriched virgin olive oil containing 500 mg PC/kg, from OO (FVOO), and (3) a PC-enriched virgin olive oil containing a mixture of 500 mg PC/kg from OO and thyme, 1:1 (FVOOT). Blood lipid values and faecal quantitative changes in microbial populations, short chain fatty acids, cholesterol microbial metabolites, bile acids, and phenolic metabolites were analysed.

resultsFVOOT decreased seric ox-LDL concentrations compared with pre-FVOOT, and increased numbers of bifidobacteria and the levels of the phenolic metabolite protocatechuic acid compared to VOO (P < 0.05). FVOO did not lead to changes in blood lipid profile nor quantitative changes in the microbial populations analysed, but increased the coprostanone compared to FVOOT (P < 0.05), and the levels of the faecal hydroxytyrosol and dihydroxyphenylacetic acids, compared with pre-intervention values and to VOO, respectively (P < 0.05).

conclusionThe ingestion of a PC-enriched virgin olive oil, containing a mixture of olive oil and thyme PC for 3 weeks, decreases blood ox-LDL in hypercholesterolemic humans. This cardio-protective effect could be mediated by the increases in populations of bifidobacteria together with increases in PC microbial metabolites with antioxidant activities.

Indexed as

AgedAntioxidantsCholesterol, HDLCholesterol, LDLCross-Over StudiesDietDouble-Blind MethodFecesFemaleGastrointestinal MicrobiomeHumansMaleMiddle AgedOlive OilPatient CompliancePhenolsAntioxidantsCholesterol, HDLCholesterol, LDLOlive OilPhenolsTriglyceridesBifidobacteriaCholesterolGut microbiotaox-LDLPhenolic compoundsPrebioticVirgin olive oil

Identifiers

PMID26541328
OpenAlexW2123016116

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.